Methylene Blue
Who holds supplier records for Methylene Blue? 9 organisations hold a current record for Methylene Blue: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: Germany (2), France (2), India (2), Italy (1) and 2 other countries (2).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Methylene Blue: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/methylene-blue
Reading the evidence
- 9 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (9)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Methylene Blue. Country is the organisation's recorded country, not necessarily the manufacturing site.
- CHEMCON GMBHGermany Company GMP cert on recordActive DMF 36353 · latest filing Jul 2022
- CHEMWERTH INCFranceActive DMF 36603 · latest filing Jun 2022
- ICROM SRLItaly Company GMP cert on recordActive DMF 36307 · latest filing Dec 2021
- KALINTIS HEALTHCARE PVT LTDIndiaActive DMF 43514 · latest filing Apr 2026
- MACSEN DRUGSIndiaActive DMF 35095 · latest filing Aug 2020
- MIKROCHEM SPOL SROSlovakiaActive DMF 31694 · latest filing Jul 2017
- PHARMAZELL GMBHGermany Company GMP cert on recordActive DMF 32900 · latest filing Sept 2023
- PROVEPHARM SASFranceActive DMF 26735 · latest filing Jan 2013
- Sichuan Qingmu Pharmaceutical Co., Ltd.ChinaActive DMF 39341 · latest filing Apr 2024
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (12 listed products contain Methylene Blue). The latest listed exclusivity runs to 8 Jan 2027. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Methylene Blue is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL550495).
Chemical identity
- IUPAC name
- [7-(dimethylamino)phenothiazin-3-ylidene]-dimethylazanium;chloride;trihydrate
- Canonical SMILES
- CN(C)C1=CC2=C(C=C1)N=C3C=CC(=[N+](C)C)C=C3S2.O.O.O.[Cl-]
- InChIKey
- XQAXGZLFSSPBMK-UHFFFAOYSA-M
- Synonyms
- Basic blue 9, Basic blue 9 trihydrate, C.I. 52015, CI 52015, CI-52015, C.i. basic blue 9, C.i. basic blue 9 trihydrate, Lowacryl blue 9, Methylene blue, Methylene blue trihydrate, Methylenium ceruleum, NSC-759135
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Oxidation-Reduction Agent
- Mechanism of action
- Oxidation-Reduction Activity
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Methylene Blue?
9 organisations hold an active US FDA Type II Drug Master File or a CEP for Methylene Blue: CHEMCON GMBH (Germany), CHEMWERTH INC (France), ICROM SRL (Italy), KALINTIS HEALTHCARE PVT LTD (India), MACSEN DRUGS (India), MIKROCHEM SPOL SRO (Slovakia), PHARMAZELL GMBH (Germany) and PROVEPHARM SAS (France), and 1 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Methylene Blue Drug Master Files are active?
CHEMCON GMBH (DMF 36353), CHEMWERTH INC (DMF 36603), ICROM SRL (DMF 36307), KALINTIS HEALTHCARE PVT LTD (DMF 43514), MACSEN DRUGS (DMF 35095), MIKROCHEM SPOL SRO (DMF 31694), PHARMAZELL GMBH (DMF 32900) and PROVEPHARM SAS (DMF 26735) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
How do I qualify a Methylene Blue supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Methylene Blue?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.